Sandra Torrades
Sandra Torrades has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ana Navarro
Primary Care Health Centre Puerta del Ángel, Madrid, Spain
1 shared publication - Concepción Pérez
Pain Clinic, Hospital Universitario de la Princesa, C/Diego de León 62, 28002, Madrid, Spain
1 shared publication - Javier Rejas
Master in Health Assessment and Market Access, Universidad Carlos III, Madrid, Spain
1 shared publication - María Teresa Saldaña
Primary Care Health Centre Raíces, Castrillón, Asturias, Spain
1 shared publication
Latest Publications
- Open Access
- 20 January 2011
- Published by Springer Nature in BMC Neurology
- Vol. 11 (1) , 7
A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
Neuropathic pain (NeP) is a common symptom of a group of a variety of conditions, including diabetic neuropathy, trigeminal neuralgia, or postherpetic neuralgia. Prevalence of NeP has been estimated to range between 5-7.5%, and produces up to 25% of pain clinics consultations. Due to its severity, chronic evolution, and associated co-morbidities, NeP has an important individual and social impact. The objective was to analyze the effect of pregabalin (PGB) on pain alleviation and longitudinal health and non-health resources utilization and derived costs in peripheral refractory NeP in routine medical practice in primary care settings (PCS) in Spain.
- 20 January 2011
- Published by Springer Nature in BMC Neurology
- Vol. 11 (1) , 7
Open AccessA Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
Neuropathic pain (NeP) is a common symptom of a group of a variety of conditions, including diabetic neuropathy, trigeminal neuralgia, or postherpetic neuralgia. Prevalence of NeP has been estimated to range between 5-7.5%, and produces up to 25% of pain clinics consultations. Due to its severity, chronic evolution, and associated co-morbidities, NeP has an important individual and social impact. The objective was to analyze the effect of pregabalin (PGB) on pain alleviation and longitudinal health and non-health resources utilization and derived costs in peripheral refractory NeP in routine medical practice in primary care settings (PCS) in Spain.